Soluble adhesion molecules in type 1 diabetes mellitus

Hormone and Metabolic Research

Volumn 29, Issue 12, 1997, Pages 639-642

  Martin, S ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chronic Inflammation; IDDM; Soluble ICAM 1

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

CONFERENCE PAPER; DIABETOGENESIS; DIAGNOSTIC VALUE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE MIGRATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031465079     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979117     Document Type: Conference Paper

References (17)

1. Arden, S. D., B. O. Roep, P. I. Neophytou, E. F. Usac. G. Duinkerken, R. R. P. Devries, J. C. Hutton: Imogen 38: A novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 97: 551-561 (1996)
2. Campbell, I. L., A. Cutri, D. Wilkinson, A. Boyd, L. C. Harrison: Intercellular adhesion molecule 1 is induced on isolated endocrine islets by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 86: 4282-4286 (1989)
3. Gearing, A. J. H., W. Newman: Circulating adhesion molecules in disease. Immunol Today 14: 506-512 (1993)
4. Lampeter, E. F., T. K. Kishimoto, R. Rothlein, E. E. Mainolfi, J. Bertrams, H. Kolb, S. Martin: Elevated levels of circulation adhesion molecules in IDDM and in subjects at risk of IDDM. Diabetes 41: 1668-1671 (1992)
5. Martin, S., J. M. Casasnovas, D. E. Staunton, T. A. Springer: Efficient disruption of rhinovirus infection in vitro by ICAM-1-immunglobulin chimeras. J Virol 67: 3561-3568 (1993)
6. Martin, S., E. Heidenthal, B. Schulte, H. Kolb: Soluble forms of intercellular adhesion molecule-1 (ICAM-1) intervene in pathogenesis of IDDM in NOD mice. Diabetologia 39: Suppl. 1, 366, A89 (1996)
7. Martin, S., I Hibino, A. Faust, R. Kleemann, H. Kolb: Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th 1-and Th2-type infiltrates. J Autoimmun 9: 637-643 (1996)
8. Martin, S., P. Rieckmann, I. Melchers, R. Wagner, J. Bertrams, A. E. Voskuyl, B. O. Roep, J. Zielasek, E. Heidenthal, I. Weichselbraun et al.: Circulating forms of ICAM-3 (cICAM-3) - Elevated levels in autoimmune diseases and lack of association with cICAM-1. J Immunol 154: 1951-1955 (1995)
9. Martin, S., H. Rothe, D. Tschöpe, B. Schwippert, H. Kolb: Decreased expression of adhesion molecules on monocytes in recent onset IDDM. Immunology 73: 123-125 (1991)
10. Roep, B. O., S. D. Arden, R. R. P. de Vries, J. C. Hutton: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632-634 (1990)
11. Roep, B. O., E. Heidenthal, R. R. P. Vries, H. Kolb, S. Martin: Soluble forms of intercellular adhesion molecule-1 (ICAM-1) intervene in antigen-specific-T-cell proliferation: A potential approach for immunotherapy. The Lancet 343: 1590-1593 (1994)
12. Rothlein, R., E. A. Mainolfi, M. Czajkowski, S. D. Marlin: A form of circulating ICAM-1 in human serum. J Immunol 147: 3788-3793 (1991)
13. Springer, T. A.: Adhesion receptors of the immune system. Nature 346: 425-434 (1990)
14. Springer, T. A.: Traffic Signals for lymphocyte recirculation and leukocyte emigration - The multistep paradigm. Cell 76: 301-314 (1994)
15. Van Seventer, G. A., Y. Shimizu, K.J. Horgan, S. Shaw: The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 144: 4579-4589 (1990)
16. Yagi, N., K Yokono, K. Amano, M. Nagata, K. Tsukamoto, Y. Hasegawa, R. Yoneda, N. Okamoto, H. Moriyama, M. Miki et al.: Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 44: 744-752 (1995)
17. Yang, X. D., S. A. Michie, R. E. Mebius, R. Tisch, I. Weissman, H. O. McDevitt: The role of cell adhesion molecules in the development of IDDM: Implications for pathogenesis and therapy. Diabetes 45: 705-710 (1996)